Key facts
- This page summarizes M. Grant Kels's Form 4 filing for Veradermics, Inc (MANE).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 05 Feb 2026, 19:05.
M. Grant Kels - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)
- Reporting relationship
- Director
- Issuer ticker
- MANE
- Reported as of
- 03 Feb 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Michael Greco, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
M. Grant Kels filed Form 4 for Veradermics, Inc (MANE) on 05 Feb 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002108622
Primary reporting owner
Grant-Kels Jane M.
- Relationship
- Director
- Address
- C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN
- Signature
- /s/ Michael Greco, Attorney-in-Fact
- Signature date
- 05 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MANE
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +2,455
- Change %
- Price
- Shares after
- 2,455
- Date
- 05 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MANE
transaction
Derivative
Series A Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -2,455
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,455
- Exercise price
- Footnotes
- F1
MANE
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +51,525
- Change %
- Price
- $0.000000
- Shares after
- 51,525
- Date
- 03 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 51,525
- Exercise price
- $17.00
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share, on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
Footnote F2
This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.